Lu Tian
Stanford University
H-index: 76
North America-United States
Top articles of Lu Tian
Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease
Acta Neuropathologica
2024/6
Discordance of patient-reported outcome measures with objectively assessed walking decline in peripheral artery disease
Journal of Vascular Surgery
2024/4/1
A rank-based approach to evaluate a surrogate marker in a small sample setting
Biometrics
2024/3
Lu Tian
H-Index: 50
Predicting clinical progression trajectories of early Alzheimer's disease patients
Alzheimer's & Dementia
2024/3
Lu Tian
H-Index: 50
Liang Zhu
H-Index: 5
Evaluating a shrinkage estimator for the treatment effect in clinical trials
Statistics in Medicine
2024/2/28
Lu Tian
H-Index: 50
Robert Tibshirani
H-Index: 110
Association of differential censoring with survival and suboptimal control arms among oncology clinical trials
JNCI: Journal of the National Cancer Institute
2024/2/9
Statistical Methods to Evaluate Surrogate Markers
Medical Care
2024/2/1
Lu Tian
H-Index: 50
Latha Palaniappan
H-Index: 40
Precision medicine analysis of heterogeneity in individual‐level treatment response to amyloid beta removal in early Alzheimer's disease
Alzheimer's & Dementia
2023/10/26
Audrey Gabelle
H-Index: 37
Lu Tian
H-Index: 50
Using Restricted Mean Survival Time to Improve Interpretability of Time-to-Event Data Analysis
Clinical Journal of the American Society of Nephrology
2024/2/1
Vivek Charu
H-Index: 21
Lu Tian
H-Index: 50
Heterogeneous Treatment Effects of Intensive Glycemic Control on Kidney Microvascular Outcomes and Mortality in ACCORD
Journal of the American Society of Nephrology
2024/1/11
Plasma pTau181 reveals a pathological signature that predicts cognitive outcomes in Lewy body disease
medRxiv
2024
Global metabolomics revealed deviations from the metabolic aging clock in colorectal cancer patients
Theranostics
2024
Empowered Relief, cognitive behavioral therapy, and health education for people with chronic pain: a comparison of outcomes at 6-month Follow-up for a randomized controlled trial
Pain Reports
2024/1/1
Anuradha Roy
H-Index: 1
Lu Tian
H-Index: 50
Assessing Response for Nivolumab Plus Ipilimumab in Squamous Cell Carcinoma of the Head and Neck
JAMA oncology
2024/1/1
Lu Tian
H-Index: 50
Home-Based Walking Exercise and Supervised Treadmill Exercise in Patients With Peripheral Artery Disease: An Individual Participant Data Meta-Analysis
JAMA network open
2023/9/5
Overall and patient-specific comparative effectiveness of dimethyl fumarate versus teriflunomide: A novel approach to precision medicine applied to the German NeuroTrans Data …
Multiple Sclerosis Journal–Experimental, Translational and Clinical
2023/7
Bootstrapping the Cross-Validation Estimate
arXiv preprint arXiv:2307.00260
2023/7/1
Vivek Charu
H-Index: 21
Lu Tian
H-Index: 50
Hierarchical Pretraining for Biomedical Term Embeddings
arXiv preprint arXiv:2307.00266
2023/7/1
Zheng Yuan
H-Index: 1
Lu Tian
H-Index: 50
Metrologically traceable quantification of 3 apolipoprotein E isoforms in cerebrospinal fluid
Clinical Chemistry
2023/7
XRRmeta: Exact Inference for Random-Effects Meta-Analyses with Rare Events
arXiv preprint arXiv:2306.11907
2023/6/20
Lu Tian
H-Index: 50
Co-Authors
